Senti Biosciences (SNTI) Other Gross PP&E Adjustments (2021 - 2025)
Senti Biosciences' quarterly Other Gross PP&E Adjustments came in at $14.4 million in Q4 2025, down 14.59% year-on-year from $16.9 million in Q4 2024, and down 22.41% quarter-over-quarter from $18.6 million in Q3 2025.
Senti Biosciences has reported Other Gross PP&E Adjustments for 5 years, with the latest figure at $14.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 14.59% year-over-year to $14.4 million; the trailing twelve-month figure through Dec 2025 stood at $14.4 million (down 14.59% YoY), and the FY2025 full-year result was $14.4 million, down 14.59% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at $14.4 million, down from $18.6 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $45.6 million in Q2 2023, with the low at -$6.7 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is $20.7 million, with a median of $17.2 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments soared 636.99% in 2022 and sank 65.33% in 2024.
- Tracing SNTI's Other Gross PP&E Adjustments over 5 years: stood at -$6.7 million in 2021, then soared by 636.99% to $35.9 million in 2022, then slumped by 57.53% to $15.2 million in 2023, then advanced by 10.8% to $16.9 million in 2024, then declined by 14.59% to $14.4 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at $14.4 million (Q4 2025), $18.6 million (Q3 2025), and $18.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.43 Mn |
| Dec 31, 2025 | 14.43 Mn |
| Sep 30, 2025 | 18.59 Mn |
| Sep 30, 2025 | 18.59 Mn |
| Jun 30, 2025 | 18.01 Mn |
| Jun 30, 2025 | 18.01 Mn |
| Mar 31, 2025 | 17.60 Mn |
| Mar 31, 2025 | 17.60 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Sep 30, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.38 Mn |
| Jun 30, 2024 | 15.81 Mn |
| Jun 30, 2024 | 15.81 Mn |
| Mar 31, 2024 | 15.66 Mn |
| Mar 31, 2024 | 15.66 Mn |
| Dec 31, 2023 | 15.25 Mn |
| Dec 31, 2023 | 15.25 Mn |
| Sep 30, 2023 | 14.66 Mn |
| Sep 30, 2023 | 14.66 Mn |
| Jun 30, 2023 | 45.61 Mn |
| Jun 30, 2023 | 45.61 Mn |
| Mar 31, 2023 | 44.50 Mn |
| Mar 31, 2023 | 44.50 Mn |
| Dec 31, 2022 | 35.90 Mn |
| Dec 31, 2022 | 35.90 Mn |
| Sep 30, 2022 | 30.93 Mn |
| Sep 30, 2022 | 30.93 Mn |
| Jun 30, 2022 | 18.15 Mn |
| Jun 30, 2022 | 18.15 Mn |
| Dec 31, 2021 | -6.69 Mn |
| Dec 31, 2021 | -6.69 Mn |